| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| David I. Rosenberg | Director | $401,396 | 01 Nov 2022 | ||
| Dr. Stephen LaMond | Interim Chief Executive Officer, Director | $5,260 | 26 Sep 2023 | ||
| MICHAEL R. FRIEDMAN | Director | $4,953 | 25 Aug 2023 | ||
| James R. Neal | Director | $0 | 14 Nov 2024 | ||
| Sandip I. Patel | Director | $0 | 14 Nov 2024 | ||
| 2014 KIF-SBI IT INVESTMENT FUND | 10%+ Owner | $0 | 04 Mar 2024 | ||
| SBI INVESTMENT KOREA CO., LTD. | Director | $0 | 07 Oct 2024 | ||
| M.D. Ph.D. Hoyoung Huh | Director, 10%+ Owner | $0 | 14 Nov 2024 | ||
| Timothy M. Cunningham | Acting Chief Financial Officer | 01 Nov 2022 | |||
| Satyajit Kumar Mitra | Executive Director, Head of Oncology | 01 Nov 2022 | |||
| Peter McCabe | General Counsel | 12 Jan 2023 | |||
| Nevan C. Elam | Director | 01 Nov 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|